Bill115th CongressFiled Jun 21, 2018Health
S. 3105
Pharmaceutical Origin Transparency Act of 2018
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in senate (Jun 21, 2018)
Pharmaceutical Origin Transparency Act of 2018
This bill amends the Federal Food, Drug, and Cosmetic Act to require a drug manufacturer to publish information about each country in which its drugs are manufactured. (A drug is manufactured in a country if the active pharmaceutical ingredient is manufactured in such country.)
What just happenedJun 21, 2018
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Who’s behind it
Sen. McCaskill, Claire [D-MO](D-MO)Sponsor
1committees2actions
- Introduced in SenateJun 21, 2018
- Jun 21, 2018IntroReferral
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Health, Education, Labor, and Pensions Committee - Jun 21, 2018IntroReferral10000
Introduced in Senate